Neuromodulation and Cognitive Control of Emotion

Meysam Amidfar, Young Hoon Ko, Yong Ku Kim

Research output: Chapter in Book/Report/Conference proceedingChapter

Abstract

Recently, noninvasive brain stimulation (NIBS) methodologies, including TMS and tDCS, have been considered as efficacious, safe, and innovative treatments and alternatives to conventional therapies for some psychiatric disorders. Developing evidence suggests that applying rTMS and tDCS over the cognitive control network (CCN), particularly the dorsolateral prefrontal cortex (DLPFC), may improve core symptoms in various psychiatric disorders via direct impact on the cognitive control processes involved in emotion regulation. Therefore, neuromodulation of brain regions involved in the cognitive control of emotion by NIBS approaches could contribute to a paradigm shift in psychiatry. The available evidence suggests that development of effective treatment alternatives to enhance cognition is critical for patients with psychiatric disorders. The purpose of this chapter is to review the cognition-enhancing properties of tDCS and TMS and the impact of these treatments on cognitive control processes, especially those related to emotion regulation in psychiatric disorders.

Original languageEnglish
Title of host publicationAdvances in Experimental Medicine and Biology
PublisherSpringer New York LLC
Pages545-564
Number of pages20
DOIs
Publication statusPublished - 2019 Jan 1

Publication series

NameAdvances in Experimental Medicine and Biology
Volume1192
ISSN (Print)0065-2598
ISSN (Electronic)2214-8019

Fingerprint

Psychiatry
Emotions
Brain
Cognition
Therapeutics
Prefrontal Cortex
Transcranial Direct Current Stimulation

Keywords

  • Cognition
  • Neuromodulation
  • Paradigm shift
  • Psychiatric disorders
  • tDCS
  • TMS

ASJC Scopus subject areas

  • Biochemistry, Genetics and Molecular Biology(all)

Cite this

Amidfar, M., Ko, Y. H., & Kim, Y. K. (2019). Neuromodulation and Cognitive Control of Emotion. In Advances in Experimental Medicine and Biology (pp. 545-564). (Advances in Experimental Medicine and Biology; Vol. 1192). Springer New York LLC. https://doi.org/10.1007/978-981-32-9721-0_27

Neuromodulation and Cognitive Control of Emotion. / Amidfar, Meysam; Ko, Young Hoon; Kim, Yong Ku.

Advances in Experimental Medicine and Biology. Springer New York LLC, 2019. p. 545-564 (Advances in Experimental Medicine and Biology; Vol. 1192).

Research output: Chapter in Book/Report/Conference proceedingChapter

Amidfar, M, Ko, YH & Kim, YK 2019, Neuromodulation and Cognitive Control of Emotion. in Advances in Experimental Medicine and Biology. Advances in Experimental Medicine and Biology, vol. 1192, Springer New York LLC, pp. 545-564. https://doi.org/10.1007/978-981-32-9721-0_27
Amidfar M, Ko YH, Kim YK. Neuromodulation and Cognitive Control of Emotion. In Advances in Experimental Medicine and Biology. Springer New York LLC. 2019. p. 545-564. (Advances in Experimental Medicine and Biology). https://doi.org/10.1007/978-981-32-9721-0_27
Amidfar, Meysam ; Ko, Young Hoon ; Kim, Yong Ku. / Neuromodulation and Cognitive Control of Emotion. Advances in Experimental Medicine and Biology. Springer New York LLC, 2019. pp. 545-564 (Advances in Experimental Medicine and Biology).
@inbook{e6ce0e28e5214836a56af98e535075b4,
title = "Neuromodulation and Cognitive Control of Emotion",
abstract = "Recently, noninvasive brain stimulation (NIBS) methodologies, including TMS and tDCS, have been considered as efficacious, safe, and innovative treatments and alternatives to conventional therapies for some psychiatric disorders. Developing evidence suggests that applying rTMS and tDCS over the cognitive control network (CCN), particularly the dorsolateral prefrontal cortex (DLPFC), may improve core symptoms in various psychiatric disorders via direct impact on the cognitive control processes involved in emotion regulation. Therefore, neuromodulation of brain regions involved in the cognitive control of emotion by NIBS approaches could contribute to a paradigm shift in psychiatry. The available evidence suggests that development of effective treatment alternatives to enhance cognition is critical for patients with psychiatric disorders. The purpose of this chapter is to review the cognition-enhancing properties of tDCS and TMS and the impact of these treatments on cognitive control processes, especially those related to emotion regulation in psychiatric disorders.",
keywords = "Cognition, Neuromodulation, Paradigm shift, Psychiatric disorders, tDCS, TMS",
author = "Meysam Amidfar and Ko, {Young Hoon} and Kim, {Yong Ku}",
year = "2019",
month = "1",
day = "1",
doi = "10.1007/978-981-32-9721-0_27",
language = "English",
series = "Advances in Experimental Medicine and Biology",
publisher = "Springer New York LLC",
pages = "545--564",
booktitle = "Advances in Experimental Medicine and Biology",

}

TY - CHAP

T1 - Neuromodulation and Cognitive Control of Emotion

AU - Amidfar, Meysam

AU - Ko, Young Hoon

AU - Kim, Yong Ku

PY - 2019/1/1

Y1 - 2019/1/1

N2 - Recently, noninvasive brain stimulation (NIBS) methodologies, including TMS and tDCS, have been considered as efficacious, safe, and innovative treatments and alternatives to conventional therapies for some psychiatric disorders. Developing evidence suggests that applying rTMS and tDCS over the cognitive control network (CCN), particularly the dorsolateral prefrontal cortex (DLPFC), may improve core symptoms in various psychiatric disorders via direct impact on the cognitive control processes involved in emotion regulation. Therefore, neuromodulation of brain regions involved in the cognitive control of emotion by NIBS approaches could contribute to a paradigm shift in psychiatry. The available evidence suggests that development of effective treatment alternatives to enhance cognition is critical for patients with psychiatric disorders. The purpose of this chapter is to review the cognition-enhancing properties of tDCS and TMS and the impact of these treatments on cognitive control processes, especially those related to emotion regulation in psychiatric disorders.

AB - Recently, noninvasive brain stimulation (NIBS) methodologies, including TMS and tDCS, have been considered as efficacious, safe, and innovative treatments and alternatives to conventional therapies for some psychiatric disorders. Developing evidence suggests that applying rTMS and tDCS over the cognitive control network (CCN), particularly the dorsolateral prefrontal cortex (DLPFC), may improve core symptoms in various psychiatric disorders via direct impact on the cognitive control processes involved in emotion regulation. Therefore, neuromodulation of brain regions involved in the cognitive control of emotion by NIBS approaches could contribute to a paradigm shift in psychiatry. The available evidence suggests that development of effective treatment alternatives to enhance cognition is critical for patients with psychiatric disorders. The purpose of this chapter is to review the cognition-enhancing properties of tDCS and TMS and the impact of these treatments on cognitive control processes, especially those related to emotion regulation in psychiatric disorders.

KW - Cognition

KW - Neuromodulation

KW - Paradigm shift

KW - Psychiatric disorders

KW - tDCS

KW - TMS

UR - http://www.scopus.com/inward/record.url?scp=85074681622&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85074681622&partnerID=8YFLogxK

U2 - 10.1007/978-981-32-9721-0_27

DO - 10.1007/978-981-32-9721-0_27

M3 - Chapter

C2 - 31705513

AN - SCOPUS:85074681622

T3 - Advances in Experimental Medicine and Biology

SP - 545

EP - 564

BT - Advances in Experimental Medicine and Biology

PB - Springer New York LLC

ER -